However, Constantino et al. [29] demonstrated in PDA cells that HuR closely associates with dCK mRNA, which in turn encodes the enzyme responsible for the metabolism and activation of gemcitabine. The gene discussed is ELAVL1; the disease is Patent ductus arteriosus.